GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tri Prime Gene Pharmaceutical Co Ltd (BJSE:837344) » Definitions » Net Interest Income

Beijing Tri Prime Gene Pharmaceutical Co (BJSE:837344) Net Interest Income : ¥-9.9 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Beijing Tri Prime Gene Pharmaceutical Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Beijing Tri Prime Gene Pharmaceutical Co's net interest income for the three months ended in Mar. 2025 was ¥-2.5 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-9.9 Mil.

Beijing Tri Prime Gene Pharmaceutical Co Net Interest Income Historical Data

The historical data trend for Beijing Tri Prime Gene Pharmaceutical Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tri Prime Gene Pharmaceutical Co Net Interest Income Chart

Beijing Tri Prime Gene Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 2.73 1.98 -0.62 -8.62

Beijing Tri Prime Gene Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.29 -1.84 -3.80 -1.69 -2.54

Beijing Tri Prime Gene Pharmaceutical Co Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-9.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tri Prime Gene Pharmaceutical Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of Beijing Tri Prime Gene Pharmaceutical Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Tri Prime Gene Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tri Prime Gene Pharmaceutical Co Ltd (BJSE:837344) » Definitions » Net Interest Income
Comparable Companies
SHSE:600200 SZSE:301258 BJSE:839729 SZSE:301166 SZSE:002868 SZSE:002566 SHSE:688137 SHSE:688098 SZSE:300149 SZSE:000518 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No. 1, Jinyuan Road, Building 4, Daxing Economic Development Zone, Daxing District, Beijing, CHN, 102600
Website
http://www.triprime.com
Beijing Tri Prime Gene Pharmaceutical Co Ltd is mainly engaged in the research, development, production, and sales of medical biotechnology products including genetic engineering drugs, genetic engineering vaccines, and diagnostic reagents, and engaged in related technical trade and technical consulting services. Its product line comprises Yundex Spray, Yundex Eye Drops, Yundexol Powder Injection, Yundexol Water Injection.

Beijing Tri Prime Gene Pharmaceutical Co Headlines

No Headlines